DIMETHYLFUMARAT Mepha Teva caps 240 mg 168 pce
7680695040036
CH-69504
L04AX07
01.99.0.
Reimbursement limitations:
DIMETHY-MEPH
Dimethylfumarat-Mepha Teva est remboursé pour le traitement des patients âgés de 18 ans et plus …
1 / 3
google
Details
- Product number
- 6950402
- CPT
- -
- Packaging group
- 168
- Unit
- Kapsel(n)
- Composition
- dimethylis fumaras 240 mg, cellulosum microcristallinum, povidonum K 30, crospovidonum, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, triacetinum, talcum, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, E 171, triethylis citras, Kapselhülle: gelatina, E 171, E 172 (flavum), E 133, Drucktinte: lacca, propylenglycolum, ammoniae solutio concentrata, kalii hydroxidum, E 172 (nigrum), pro capsula.
Articles (1)
Dimethylfumarat-Mepha Teva 240 mg, magensaftresistente Hartkapseln
Magensaftresistente Hartkapseln
168
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
240.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FNIDK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | FIMDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FTODK |
Reimbursement information
Public price
CHF 1176.35
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/09/2024
Authorization holder
Mepha Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 69504
- Drug name
- Dimethylfumarat-Mepha Teva, magensaftresistente Hartkapseln
- Galenic form
- KAHAM
- ATC Code
- L04AX07
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 08/08/2024
- Authorization expiration date
- 07/08/2029
- IT number
- 01.99.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- DIMETHYLFUMARAT Mepha Teva caps 240 mg 168 pce
- Description (DE)
- DIMETHYLFUMARAT Mepha Teva Kaps 240 mg 168 Stk
- Market launch
- 08/08/2024
- Narcotic (BTM)
- No